The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery disease (Q86342700)
Jump to navigation
Jump to search
scientific article published on 11 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery disease |
scientific article published on 11 March 2013 |
Statements
The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery disease (English)
Anja Vogt
Klaus G Parhofer
11 March 2013